Functional nanovesicles displaying anti-PD-L1 antibodies for programmed photoimmunotherapy

BACKGROUND: Photoimmunotherapy is one of the most promising strategies in tumor immunotherapies, but targeted delivery of photosensitizers and adjuvants to tumors remains a major challenge. Here, as a proof of concept, we describe bone marrow mesenchymal stem cell-derived nanovesicles (NVs) displayi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hu, Zhang, Pengfei, Shi, Yesi, Liu, Chao, Zhou, Qianqian, Zeng, Yun, Cheng, Hongwei, Dai, Qixuan, Gao, Xing, Wang, Xiaoyong, Liu, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811970/
https://www.ncbi.nlm.nih.gov/pubmed/35109867
http://dx.doi.org/10.1186/s12951-022-01266-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811970/
https://www.ncbi.nlm.nih.gov/pubmed/35109867
http://dx.doi.org/10.1186/s12951-022-01266-3

Ejemplares similares